4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-018513
Options or other derivatives
- Chief Financial Officer acquired 43,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| TOMSICEK MICHAEL JOHN Chief Financial Officer | 2020-03-10 | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | D | ||
| TOMSICEK MICHAEL JOHN Chief Financial Officer | 2020-03-10 | Grant or award · Restricted Stock Units | +8,500 | 8,500 | D | ||
Loading xslF345X03/doc4.xml…